Clena-Med, Clenbuterol Hydrochloride, 0.04 mg, 120 Tabs

CLENA-MED 40 mcg by Bioniche Pharma contains Clenbuterol Hydrochloride, a potent sympathomimetic amine featuring high selectivity for $\beta_2$-adrenergic receptors. Originally developed as an extended-action bronchodilator to alleviate airway constriction, Bioniche Pharma CLENA-MED drives adrenoreceptor-mediated physiological pathways to deliver thermogenic, metabolic, and central nervous system stimulation.

CLINICAL PHARMACOLOGY & DYNAMICS

By selectively stimulating $\beta_2$-adrenoreceptors across bronchial smooth muscle tissue, Clenbuterol Hydrochloride in Bioniche Pharma CLENA-MED induces rapid airway relaxation, optimizing pulmonary airflow and systemic oxygen uptake. Simultaneously, its systemic sympathomimetic activity raises resting metabolic rate, enhances aerobic efficiency, stimulates central nervous system alertness, and can produce transient increases in heart rate and systemic blood pressure.

INDICATIONS & CLINICAL USE

• Prophylaxis and symptomatic management of reversible airway obstruction disorders (such as bronchial asthma and chronic obstructive pulmonary disease / COPD) using Bioniche Pharma CLENA-MED.
• Therapeutic relaxation of bronchial smooth muscle to restore optimal respiratory mechanics under strict medical direction.

DOSAGE & ADMINISTRATION

Dosing strategies for CLENA-MED by Bioniche Pharma must be individually calculated, initiated at conservative baseline dosages, and monitored under direct physician oversight to mitigate systemic sympathomimetic side effects.

CONTRAINDICATIONS

• Acute myocardial infarction, severe ischemic heart disease, cardiac hypertrophic subaortic stenosis, or tachyarrhythmias.
• Pregnancy and nursing owing to uterine smooth muscle relaxation (tocolytic effects) and potential risks of cardiovascular fetal toxicity.
• Known hypersensitivity or allergic reaction to Clenbuterol Hydrochloride or inactive compounding excipients in Bioniche Pharma tablets.

ADVERSE REACTIONS & WARNINGS

Continuous clinical oversight is indicated during Bioniche Pharma CLENA-MED therapy to screen for sympathomimetic and cardiovascular adverse effects:

• Cardiovascular: Sinus tachycardia, palpitations, elevated arterial blood pressure, aggravation of subaortic stenosis, and heightened myocardial workload linked to Bioniche Pharma CLENA-MED administration.
• Endocrine & Systemic: Exacerbation of thyrotoxicosis manifestations, fine peripheral muscle tremors, nervousness, heightened anxiety, and insomnia reported during Bioniche Pharma treatment.
• Hypersensitivity: Dermatological eruptions, urticaria, pruritus, or systemic allergic reactions experienced during therapy.

STORAGE & HANDLING

Store Bioniche Pharma CLENA-MED in a dry, cool location protected from direct light exposure and excess moisture. Keep strictly out of the reach and sight of children.